JPS4921148B1 - - Google Patents
Info
- Publication number
- JPS4921148B1 JPS4921148B1 JP12760970A JP12760970A JPS4921148B1 JP S4921148 B1 JPS4921148 B1 JP S4921148B1 JP 12760970 A JP12760970 A JP 12760970A JP 12760970 A JP12760970 A JP 12760970A JP S4921148 B1 JPS4921148 B1 JP S4921148B1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Plural Heterocyclic Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP12760970A JPS4921148B1 (xx) | 1970-12-28 | 1970-12-28 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP12760970A JPS4921148B1 (xx) | 1970-12-28 | 1970-12-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPS4921148B1 true JPS4921148B1 (xx) | 1974-05-30 |
Family
ID=14964306
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP12760970A Pending JPS4921148B1 (xx) | 1970-12-28 | 1970-12-28 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS4921148B1 (xx) |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0781766A4 (en) * | 1994-09-09 | 1998-01-14 | Nippon Shinyaku Co Ltd | HETEROCYCLIC DERIVATIVE AND MEDICINAL PRODUCT |
| EP1786800A4 (en) * | 2004-08-13 | 2009-05-06 | Neurogen Corp | SUBSTITUTED BIARYL PIPERAZINYL-PYRIDINE ANALOGUES |
| WO2009066084A1 (en) * | 2007-11-21 | 2009-05-28 | F. Hoffmann-La Roche Ag | 2 -morpholinopyrimidines and their use as pi3 kinase inhibitors |
| US8865894B2 (en) | 2012-02-24 | 2014-10-21 | Novartis Ag | Oxazolidin-2-one compounds and uses thereof |
| US8957068B2 (en) | 2011-09-27 | 2015-02-17 | Novartis Ag | 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH |
| US9296733B2 (en) | 2012-11-12 | 2016-03-29 | Novartis Ag | Oxazolidin-2-one-pyrimidine derivative and use thereof for the treatment of conditions, diseases and disorders dependent upon PI3 kinases |
| US9434719B2 (en) | 2013-03-14 | 2016-09-06 | Novartis Ag | 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH |
| US10064869B2 (en) | 2014-06-04 | 2018-09-04 | Thomas Helledays Stiftelse For Medicinsk Forskning | MTH1 inhibitors for treatment of inflammatory and autoimmune conditions |
-
1970
- 1970-12-28 JP JP12760970A patent/JPS4921148B1/ja active Pending
Cited By (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0781766A4 (en) * | 1994-09-09 | 1998-01-14 | Nippon Shinyaku Co Ltd | HETEROCYCLIC DERIVATIVE AND MEDICINAL PRODUCT |
| EP1786800A4 (en) * | 2004-08-13 | 2009-05-06 | Neurogen Corp | SUBSTITUTED BIARYL PIPERAZINYL-PYRIDINE ANALOGUES |
| US7662830B2 (en) | 2004-08-13 | 2010-02-16 | Neurogen Corporation | Substituted biaryl piperazinyl-pyridine analogues |
| WO2009066084A1 (en) * | 2007-11-21 | 2009-05-28 | F. Hoffmann-La Roche Ag | 2 -morpholinopyrimidines and their use as pi3 kinase inhibitors |
| US8957068B2 (en) | 2011-09-27 | 2015-02-17 | Novartis Ag | 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH |
| US8865894B2 (en) | 2012-02-24 | 2014-10-21 | Novartis Ag | Oxazolidin-2-one compounds and uses thereof |
| US9296733B2 (en) | 2012-11-12 | 2016-03-29 | Novartis Ag | Oxazolidin-2-one-pyrimidine derivative and use thereof for the treatment of conditions, diseases and disorders dependent upon PI3 kinases |
| US10202371B2 (en) | 2012-11-12 | 2019-02-12 | Novartis Ag | Oxazolidin-2-one-pyrimidine derivatives and the use thereof as phosphatidylinositol-3-kinase inhibitors |
| US9434719B2 (en) | 2013-03-14 | 2016-09-06 | Novartis Ag | 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH |
| US9688672B2 (en) | 2013-03-14 | 2017-06-27 | Novartis Ag | 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH |
| US10112931B2 (en) | 2013-03-14 | 2018-10-30 | Novartis Ag | 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH |
| US10064869B2 (en) | 2014-06-04 | 2018-09-04 | Thomas Helledays Stiftelse For Medicinsk Forskning | MTH1 inhibitors for treatment of inflammatory and autoimmune conditions |
| US10632125B2 (en) | 2014-06-04 | 2020-04-28 | Thomas Helledays Stiftelse For Medicinsk Forskning | MTH1 inhibitors for treatment of inflammatory and autoimmune conditions |